0 Комментарии
0 Поделились
416 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Carbamazepine in Epilepsy Treatment: Market Growth and InnovationA large number of people with epilepsy are under treatment from carbamazepine, the internationally renowned antiepileptic and antipsychotic drug. Carbamazepine market poised for signijl growth yet it faces various dangers and opportunities. This paper will examine some current trends challenges and potential prospects in the future of global Carbamazepine industry. Market Overview Favorable...0 Комментарии 0 Поделились 217 Просмотры 0 предпросмотр
- Childhood Absence Epilepsy Treatment Market is driven by increasing awareness initiativesThe childhood absence epilepsy treatment market comprises medications, surgical procedures, and devices that are mainly focused on reducing seizure frequency and improving quality of life. Childhood absence epilepsy includes seizures characterized by brief periods of staring episodes and lack of awareness. Drugs such as ethosuximide, valproic acid, and lamotrigine are widely used as first-line...0 Комментарии 0 Поделились 618 Просмотры 0 предпросмотр
- Childhood Absence Epilepsy Treatment Market Owing to Increasing Prevalence of Childhood Absence Epilepsy GloballyThe Childhood Absence Epilepsy Treatment market is estimated to be valued at US$ 238.05 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Childhood absence epilepsy is a common form of epilepsy seen in children between the ages of 4 to 12 years marked with brief and...0 Комментарии 0 Поделились 1211 Просмотры 0 предпросмотр
- Epilepsy Diagnosis and Treatment Market Size, by Technology, Share, Size, Segmentation, Revenue Analysis Forecast 2030Epilepsy Diagnosis and Treatment Market Highlights Increasing prevalence of epilepsy, rising number of traumatic brain injury cases, growing geriatric population, and rising healthcare expenditures are the major drivers for the global Epilepsy Diagnosis and Treatment Market However, high cost of therapeutic surgeries, low per capita healthcare expenditure, and lack of awareness for the disease...0 Комментарии 0 Поделились 1589 Просмотры 0 предпросмотр
- Insights into Childhood Absence Epilepsy Treatment Market: Driving Factors and Strategic AnalysisThe Childhood Absence Epilepsy Treatment Market is witnessing significant growth, primarily driven by several key factors. One of the primary drivers is the increasing prevalence of childhood absence epilepsy (CAE) worldwide. CAE is one of the most common forms of pediatric epilepsy, characterized by brief, sudden lapses in consciousness or absence seizures. With improving diagnostic techniques...0 Комментарии 0 Поделились 1020 Просмотры 0 предпросмотр
- Managing Childhood Absence Epilepsy Treatment Options and PrognosisTreatment Monitoring and Adjustments If seizures are adequately controlled on initial drug therapy, then long-term treatment may not be required. However, medications need to be continued for at least 2-3 years after seizure remission to prevent relapses. Drug levels are monitored regularly to ensure proper dosage. Adjustments may be made based on response and tolerability. Good compliance and...0 Комментарии 0 Поделились 999 Просмотры 0 предпросмотр
- Vagus Nerve Stimulation: A Promising Treatment for Epilepsy and Other ConditionsEpilepsy is one of the main conditions where Vagus Nerve Stimulators has shown effectiveness. Multiple clinical trials found that VNS reduced seizure frequency in about half of patients who did not respond well to seizure medications alone. It typically takes a few months after implantation for VNS to reach its full effect. Studies have found 30-50% of patients experience a 50% or greater...0 Комментарии 0 Поделились 905 Просмотры 0 предпросмотр
- Vagus Nerve Stimulators: An Emerging Epilepsy TreatmentWhat is Vagus Nerve Stimulation?Vagus nerve stimulation (VNS) is a medical treatment for epilepsy and treatment-resistant depression. It involves a device placed surgically under the skin in the chest region that is connected to the vagus nerve in the neck. The vagus nerve is responsible for communicating signals between the brain and different organs in the body including the heart, lungs, and...0 Комментарии 0 Поделились 526 Просмотры 0 предпросмотр
- Advancing Seizure Management: Key Drivers and Market Outlook for Epilepsy TreatmentsEpilepsy Treatment Market was valued at USD 4.30 Billion in 2023, and it is expected to reach USD 7.04 Billion by 2030, exhibiting a CAGR of 7.3% during the forecast period (2024-2030). Epilepsy Treatment Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Epilepsy Treatment Market”. The report...0 Комментарии 0 Поделились 67 Просмотры 0 предпросмотр
- Epilepsy Drugs Market will grow at highest pace owing to high unmet needsThe epilepsy drugs market comprises anti-epileptic drugs that are primarily used to treat epilepsy and seizures. Epilepsy is a neurological disorder characterized by recurrent and unprovoked seizures. Major anti-epileptic drugs in the market are first, second and third generation drugs that include sodium channel blockers, GABAergics, and combination therapeutics. First generation drugs include...0 Комментарии 0 Поделились 84 Просмотры 0 предпросмотр
- The Global Acute Repetitive Seizures Market Is Driven By Rising Incidence Of EpilepsyThe global acute repetitive seizures market covers products that are used for management of acute repetitive seizures arising due to conditions like epilepsy. Acute repetitive seizures occur when a person experiences two or more seizures without regaining consciousness between seizures and can be potentially life-threatening if not treated promptly. Drugs that help terminate acute repetitive...0 Комментарии 0 Поделились 804 Просмотры 0 предпросмотр
Расширенные страницы